Page 95 - Applied Computer Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Applied computer science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Applied Computer Science Today - Breaking & Trending Today

Youtube Bans National Amnesty Opposing Org's Channel

Youtube Bans National Amnesty Opposing Org s Channel
Youtube Bans National Amnesty Opposing Org s Channel
Censorship Corresponds with Amnesty Legislation Battle in DC
For National Release | March 11, 2021
Youtube has removed the channel ALIPAC1 of the national organization Americans for Legal Immigration PAC without warning or three strikes while making false accusations that the contents of the channel, which has been up since 2009, engaged in severe or repeated violations of our Community Guidelines. (Email copies available upon request)
ALIPAC believes the ban by Youtube is retaliation against current activist efforts to stop Amnesty for illegals legislation in DC and the ALIPAC s formal complaint with the Federal Elections Commission, Matter Under Review (MUR #7834) (VIEW HERE), which accuses Google/Youtube of violating election laws by using censorship and shadowbanning to exert unfair influence over US elections and legislation. ....

United States , Big Tech , Illegal Immigration , Google Youtube , Http Www Alipac Us , Alipac Us , ஒன்றுபட்டது மாநிலங்களில் , பெரியது தொழில்நுட்பம் , சட்டவிரோதமானது குடியேற்றம் , கூகிள் வலைஒளி ,

ElectrifAi Achieves AWS Machine Learning Competency Status in Applied [...]

11 marzo 2021 06:46
Fonte: Adnkronos
#ict
JERSEY CITY, N.J., March 10, 2021 /PRNewswire/ ElectrifAi, one of the world s leading companies in practical artificial intelligence (AI) and pre-built machine learning (ML) models, today announced that it has achieved Amazon Web Services (AWS) Machine Learning Competency status in the new Applied Artificial Intelligence (Applied AI) category. This designation recognizes that ElectrifAi has demonstrated deep experience and expertise in building or integrating practical ML solutions on AWS.
AWS Partners recognized as part of the AWS Machine Learning Competency expansion help customers take advantage of intelligent solutions to drive business optimization, customer revenue growth and cost reduction. This is done by creating, automating, and managing end-to-end ML workflows with machine intelligence. ....

New Delhi , Julien Simon , Gilles Louwerens , Jim Mcgowan , Amazon Web Services , Competency Program , Machine Learning Competency , Applied Artificial Intelligence , Learning Competency , Cloud Partners , Amazon Sagemaker , Data Science , Business Intelligence , Jersey City , புதியது டெல்ஹி , ஜூலியன் சிமோன் , ஜிம் மகோவெந் , அமேசான் வலை சேவைகள் , திறன் ப்ரோக்ர்யாம் , இயந்திரம் கற்றல் திறன் , பயன்படுத்தப்பட்டது செயற்கை உளவுத்துறை , கற்றல் திறன் , மேகம் கூட்டாளர்கள் , தகவல்கள் அறிவியல் , வணிக உளவுத்துறை , ஜெர்சி நகரம் ,

GCP Applied Technologies Reports Preliminary Fourth Quarter and Full Year 2020 Results

Fourth Quarter 2020 - Preliminary 4Q 2020 Net sales $243 million, down 6.0% 4Q 2020 Gross margin 39.5%, an increase of 150 basis points 4Q 2020 Loss from ....

United Kingdom , United States , Betsy Cowell , Simon Bates , Asia Pacific , Exchange Commission , Technologies Inc , Securities Exchange , World Health Organization , Sales Constant Currency Excluding Market , Chief Executive Officer , Adjusted Free Cash , Constant Currency Excluding Market , Previously Issued Consolidated Financial , Net Sales Constant Currency , Adjusted Gross Profit , Adjusted Gross Margin , Adjusted Free Cash Flow , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Months Ended December , Ended December , Earnings Per Share Attributable , Balance Sheets , Stockholder Equity ,

Umbra Applied Technologies Group Inc: UAT Group Inc, Acquires 20% of Next Casting Technologies

Umbra Applied Technologies Group Inc: UAT Group Inc, Acquires 20% of Next Casting Technologies
Tampa, Florida (Newsfile Corp. - March 4, 2021) - Umbra Applied Technologies Group, Inc (OTC Pink: UATG) announced today that it has purchased 20% of the Austin, Texas based medical company Next Casting Technologies. The global orthopedic casting, splinting, braces and support market was valued at US $4.6 billion in 2015 and is expected to reach US $7.9 billion by 2024, at a CAGR of 6.4%. Next Casting Technologies has projected its first-year revenues to be $16.1M once it launches with a five-year evaluation in excess of $80M. UAT Group will deliver the $5M purchase price amortized over the next 24 months. ....

United States , Kostenloser Wertpapierhandel , Umbra Applied Technologies Group Inc , Florida Newsfile Corp , Umbra Applied Technologies Group , Applied Technologies Group , Next Casting , Next Casting Technologies , Executive Officer , Alex Umbra , Next Cast , Casting Technologies , Tampa Florida , Media Contact , ஒன்றுபட்டது மாநிலங்களில் , உம்பிர பயன்படுத்தப்பட்டது தொழில்நுட்பங்கள் குழு இன்க் , உம்பிர பயன்படுத்தப்பட்டது தொழில்நுட்பங்கள் குழு , பயன்படுத்தப்பட்டது தொழில்நுட்பங்கள் குழு , அடுத்தது வார்ப்பு , அடுத்தது வார்ப்பு தொழில்நுட்பங்கள் , நிர்வாகி அதிகாரி , அலெக்ஸ் உம்பிர , அடுத்தது நடிகர்கள் , வார்ப்பு தொழில்நுட்பங்கள் , தம்பா புளோரிடா , மீடியா தொடர்பு ,

Applied DNA Sciences, Inc.: Applied DNA and Evvivax Initiate Phase I of Clinical Trial to Evaluate LinearDNA COVID-19 Vaccine Candidate for Feline Veterinary Market

(2)
- Vaccine Candidate Previously Demonstrated Antibodies and T-cell Response in Mouse Models
- Clinical Trial to Serve as Initial Validation of LinearDNA Platform in Large Mammals with Potential Advantages in Manufacturing, Storage, and Distribution over Other Vaccines
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the Company ), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. ( Evvivax ), today announced the initiation of Phase I of a two-phase clinical trial to evaluate a LinearDNA COVID-19 vaccine candidate for the feline veterinary market. The goal of the trial is to evaluate the vaccine candidate as a strategy for the prevention of SARS-CoV-2, the virus that causes COVID-19, in feline companions of humans that may mitigate the animals as a potential reservoir for infections in humans. If successful, the clinical trial will also serve as an important initial validation of LinearDNA, Appl ....

United States , Joseph Impellizeri , Jamesa Hayward , Luigi Aurisicchio , Us Department Of Agriculture , Sciences Inc , Drug Administration , Veterinary Oncology Services At Guardian Specialists , Securities Exchange , American Veterinary Medical Association , Plant Health Inspection Service , Candidate Previously Demonstrated Antibodies , T Cell Response , Mouse Models , Initial Validation , Large Mammals , Potential Advantages , Polymerase Chain Reaction , Takis Biotech , Veterinary Oncology Services , Guardian Veterinary Specialists , Supervising Investigator , American College , Veterinary Internal Medicine , Russell Microcap , Looking Statements ,